VAS
TEVA icon

Vestmark Advisory Solutions’s Teva Pharmaceuticals TEVA Stock Holding History

Vestmark Advisory Solutions’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$307K Sell
9,069
-15,205
-63% -$506K ﹤0.01% 1261
2026
Q1 		$731K Buy
+24,274
New +$781K 0.01% 957

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Vestmark Advisory Solutions's TEVA Position: Q2 2026 in Review

Vestmark Advisory Solutions reduced its Teva Pharmaceuticals (TEVA) stake by 63% in Q2 2026, selling an estimated $506K and leaving 9,069 shares worth $307K. The position accounts for ﹤0.01% of the portfolio, ranked #1261.

Vestmark Advisory Solutions first reported a position in TEVA in Q1 2026 and has held it in 2 quarters since. The position peaked at $731K in Q1 2026. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Vestmark Advisory Solutions held 9,069 shares of Teva Pharmaceuticals worth $307K as of Q2 2026.
  • Vestmark Advisory Solutions sold 15,205 Teva Pharmaceuticals shares in Q2 2026, an estimated $506K.
  • Teva Pharmaceuticals made up ﹤0.01% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #1261 holding.
  • Vestmark Advisory Solutions first reported a position in Teva Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Vestmark Advisory Solutions's Teva Pharmaceuticals position peaked at $731K in Q1 2026.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.